June 3, 2024 New Topical Antipruritic Spray Shows Promise in Treating EGFR-Related Dermatitis Conexiant
June 03, 2024 Neoadjuvant Immunotherapy Combination Improves Outcomes in Patients With Melanoma The ASCO Post
May 27, 2021 Study Finds Adjuvant Immunotherapy of Benefit to Patients With Stage IIB/C Melanoma The ASCO Post
April 17, 2023 Single-Agent Pembrolizumab May Benefit Patients With Advanced Desmoplastic Melanoma The ASCO Post
June 23, 2023 SWOG S1512 Trial: Pembrolizumab Achieves High Response Rates in Rare Type of Melanoma The ASCO Post